Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Unusual subtypes of prostate cancer.

Grignon DJ.

Mod Pathol. 2004 Mar;17(3):316-27. Review.

2.
3.

Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.

Fine SW.

Adv Anat Pathol. 2012 Jul;19(4):204-16. doi: 10.1097/PAP.0b013e31825c6b92. Review.

PMID:
22692283
4.

[Histological classification of prostatic cancer].

Sakamoto A, Terado Y.

Nihon Rinsho. 1998 Aug;56(8):1959-62. Review. Japanese.

PMID:
9750487
5.

Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.

Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL.

Adv Anat Pathol. 2006 Jan;13(1):57-9.

PMID:
16462155
6.

Histologic classification of prostate cancer.

Mikuz G.

Anal Quant Cytopathol Histpathol. 2015 Feb;37(1):39-47. Review.

PMID:
26072633
7.

Histopathologic diagnosis and classification of prostate adenocarcinoma: biologic significance.

Peters JM, Crissman JD.

Henry Ford Hosp Med J. 1989;37(1):8-13. Review.

PMID:
2670842
8.

Low Gleason score prostatic adenocarcinomas are no longer viable entities.

Berney DM.

Histopathology. 2007 May;50(6):683-90. Review.

PMID:
17493232
9.

Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance.

Randolph TL, Amin MB, Ro JY, Ayala AG.

Mod Pathol. 1997 Jun;10(6):612-29. Review.

PMID:
9195581
10.

Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made.

Epstein JI.

Am J Surg Pathol. 2000 Apr;24(4):477-8. Review. No abstract available.

PMID:
10757394
11.

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications.

Andreoiu M, Cheng L.

Hum Pathol. 2010 Jun;41(6):781-93. doi: 10.1016/j.humpath.2010.02.011. Review.

PMID:
20466122
12.

The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.

Billis A, Guimaraes MS, Freitas LL, Meirelles L, Magna LA, Ferreira U.

J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11.

PMID:
18550106
13.

The prostatic gland: malignancies other than adenocarcinomas.

Varghese SL, Grossfeld GD.

Radiol Clin North Am. 2000 Jan;38(1):179-202. Review.

PMID:
10664672
14.
15.

Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.

Damiano R, Di Lorenzo G, Cantiello F, De Sio M, PerdonĂ  S, D'Armiento M, Autorino R.

Eur Urol. 2007 Sep;52(3):648-57. Epub 2007 Jun 21. Review.

PMID:
17600614
16.

Histopathology reporting of prostate needle biopsies. 2005 update.

Montironi R, Vela Navarrete R, Lopez-Beltran A, Mazzucchelli R, Mikuz G, Bono AV.

Virchows Arch. 2006 Jul;449(1):1-13. Epub 2006 Apr 22. Review.

PMID:
16633784
17.

[Prostate cancer. Epidemiology. Risk factors. Pathology].

Fournier G, Valeri A, Mangin P, Cussenot O.

Ann Urol (Paris). 2004 Oct;38(5):187-206. Review. French.

PMID:
15570704
18.

Does finasteride alter the pathology of the prostate and cancer grading?

Bostwick DG, Qian J, Civantos F, Roehrborn CG, Montironi R.

Clin Prostate Cancer. 2004 Mar;2(4):228-35. Review.

PMID:
15072606
19.

The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review.

Harnden P, Shelley MD, Clements H, Coles B, Tyndale-Biscoe RS, Naylor B, Mason MD.

Cancer. 2007 Jan 1;109(1):13-24. Review.

20.

[Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry].

Bonkhoff H.

Pathologe. 2005 Nov;26(6):405-21. Review. German.

PMID:
16205899

Supplemental Content

Support Center